High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients.
about
Effect of Cigarette Smoking on Epithelial to Mesenchymal Transition (EMT) in Lung CancerForkhead box C1 induces epithelial‑mesenchymal transition and is a potential therapeutic target in nasopharyngeal carcinomaFOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast CancerComparison of Bioinformatics Prediction, Molecular Modeling, and Functional Analyses of FOXC1 Mutations in Patients with Axenfeld-Rieger SyndromeTumor Hypoxia Regulates Forkhead Box C1 to Promote Lung Cancer ProgressionIdentification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer.A novel long non-coding RNA FOXCUT and mRNA FOXC1 pair promote progression and predict poor prognosis in esophageal squamous cell carcinoma.FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.miR-639 regulates transforming growth factor beta-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting FOXC1.FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance.FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort.FOXC1 promotes melanoma by activating MST1R/PI3K/AKT.FOXC1 promotes proliferation and epithelial-mesenchymal transition in cervical carcinoma through the PI3K-AKT signal pathway.MicroRNA-204-5p inhibits invasion and metastasis of laryngeal squamous cell carcinoma by suppressing forkhead box C1.The long noncoding RNA FOXCUT promotes proliferation and migration by targeting FOXC1 in nasopharyngeal carcinoma.Identification of genes associated with renal cell carcinoma using gene expression profiling analysis.The expression and functional role of a FOXC1 related mRNA-lncRNA pair in oral squamous cell carcinoma.FOXC1: an emerging marker and therapeutic target for cancer.Forkhead box C1 is targeted by microRNA-133b and promotes cell proliferation and migration in osteosarcomaCharacterization of the genomic architecture and mutational spectrum of a small cell prostate carcinomaThe forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemia.FOXC1 in cancer development and therapy: deciphering its emerging and divergent roles.Forkhead box protein C1 promotes cell proliferation and invasion in human cervical cancer.miR-582-5p inhibits invasion and migration of salivary adenoid cystic carcinoma cells by targeting FOXC1.Overexpression of FOXC1 correlates with poor prognosis in gastric cancer patients.Research progress on the forkhead box C1.Down-regulation of MicroRNA-133 predicts poor overall survival and regulates the growth and invasive abilities in glioma.FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC
P2860
Q26748357-A6E30BC2-9C64-4BD0-8AE5-FBE39C728A19Q28268527-9C45CEAF-0EFD-4FE6-B203-EBCE5D44F3F0Q28269779-B91C9C59-7432-4220-8D5C-58C005537A20Q28941779-C1EB1BB8-4B3C-4E40-AED0-5254979A290DQ33588186-90507403-ECAB-4CE0-A941-21DCBC99F3B1Q33814357-35667735-E3DF-4673-8EED-4CDC1C927F2CQ33898799-DDD36CF2-2EFE-4116-AC70-EC0C9A306484Q34543873-294751DD-8325-4838-8396-DCF9D03EAC22Q35713143-3E5891CB-5730-493A-85A3-5C436C97EAE3Q37619126-F32029CB-B29A-432D-86B2-813BFF333914Q37689013-229B0E91-164F-441D-85D3-7199071E5A0FQ37708952-08C9FDE6-CBD2-4774-A3A3-1FB30FA2E937Q37733027-E47CA144-6D9F-447E-8B7A-6AFE1FC4E1C6Q38640499-5E1B1C9C-7C75-4DCD-B186-83721F8C04D1Q38699560-61B13846-4FA6-400D-A2FC-B40853411FD5Q38848220-74DBE791-FA1C-482C-AAD1-6A5658BC7991Q38989090-A72002CC-A2EF-4203-80BA-9C0CE6E3C457Q39176111-FA8835B0-D8F9-4FB7-A6B3-8D0003422CEEQ41623598-FA11E0C5-432A-4F6E-836B-895B1B41A5A5Q41873815-E45AC5F6-6000-40B1-A63A-AE3C72D41E8FQ43914090-88872028-E991-4CD6-B335-AC3B1C23EB18Q49624286-43A39621-37C5-42E4-9AF4-2E0356A5526AQ50068119-F2F771CE-4573-4535-8F1F-EC632325C622Q50596382-7DADD937-587C-42AD-BDD2-59652C95F134Q51525514-63BE6F20-B430-4E06-ABCD-B9DF4E36F684Q53701147-D9ACD0A8-8537-4587-8E5F-D041F812BBC5Q55458536-5D26DF05-43E0-47F2-8438-854131C832CDQ58761835-52B39E42-7A06-4C86-8CA0-52831956C34C
P2860
High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
High expression of FOXC1 is as ...... all cell lung cancer patients.
@en
High expression of FOXC1 is as ...... all cell lung cancer patients.
@nl
type
label
High expression of FOXC1 is as ...... all cell lung cancer patients.
@en
High expression of FOXC1 is as ...... all cell lung cancer patients.
@nl
prefLabel
High expression of FOXC1 is as ...... all cell lung cancer patients.
@en
High expression of FOXC1 is as ...... all cell lung cancer patients.
@nl
P2093
P2860
P1433
P1476
High expression of FOXC1 is as ...... all cell lung cancer patients.
@en
P2093
Hai-Feng Xu
Jun-Yan Wang
Long-Xiao Wei
Meng-Hui Yuan
Run-Suo Zhou
P2860
P2888
P304
P356
10.1007/S13277-012-0629-3
P577
2012-12-22T00:00:00Z